+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Percutaneous device closure of patent foramen ovale using the Premere occlusion device: initial experience, procedural, and intermediate-term results

Percutaneous device closure of patent foramen ovale using the Premere occlusion device: initial experience, procedural, and intermediate-term results

Journal of Invasive Cardiology 24(4): 164-168

Percutaneous device closure is a therapeutic option in patients with presumed stroke complicating paradoxical emboli. Newer devices with lower profiles and potentially reduced thrombogenicity have emerged, such as the Premere PFO occlusion device (St Jude Medical, Inc.); there are limited data on the efficacy and procedural experience with this device. We evaluated our initial experience with the Premere device in a contemporary patient cohort, comparing the procedural and intermediate follow-up characteristics with the currently utilized Amplatzer PFO occluder. Both devices were similarly effective in terms of immediate procedural success and defect closure. Procedures using the Premere device tended to be longer and required larger vascular access-sheath sizes; there were also significantly more adverse events in the Premere group (4/29) compared to the Amplatzer group (0/42; P=.02), including 1 retroperitoneal bleed, 2 hematomas, and 1 myocardial infarction. While the Amplatzer device may offer advantages in terms of safety and procedural simplicity, this in part reflects the early procedural experience with this new device. The Premere and Amplatzer PFO occlusion devices are similarly effective in achieving PFO closure when applied to appropriate anatomy and should be considered complementary when performing such procedures.

(PDF emailed within 1 workday: $29.90)

Accession: 054921130

Download citation: RISBibTeXText

PMID: 22477752

Related references

Patent foramen ovale closure using the premere device. Herz 31(6): 597, 2006

Premere occlusion system for transcatheter patent foramen ovale closure: mid-term results of a single-center registry. Catheterization and Cardiovascular Interventions 77(4): 564-569, 2011

Patent foramen ovale closure with the SeptRx device initial experience with the first "In-Tunnel" device. Jacc. Cardiovascular Interventions 3(9): 963-967, 2011

Intermediate and long-term results of transcatheter closure of patent foramen ovale using the amplatzer patent foramen ovale occluder: one case of pulmonary embolism irrespective of patent foramen ovale closure. Korean Circulation Journal 41(7): 356-362, 2011

Patent foramen ovale using the Premere device: the results of the CLOSEUP trial. Journal of Interventional Cardiology 19(4): 328-333, 2006

Experience with the Amplatzer and PFOStar device for percutaneous closure of patent foramen ovale. Circulation 106(19 Supplement): II-576, November 5, 2002

Percutaneous closure of patent foramen ovale with a bioabsorbable occluder device: single-centre experience. Catheterization and Cardiovascular Interventions 74(4): 607-614, 2009

Results of US phase I clinical trial of closure of patent foramen ovale associated with stroke/transient ischemic attack of peripheral embolism using the Amplatzer patent foramen ovale device. Journal of the American College of Cardiology 41(6 Supplement A): 75A, March 19, 2003

Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism: procedural and follow-up results after implantation of the Amplatzer®-occluder device. Journal of Interventional Cardiology 24(1): 85-91, 2011

Transcatheter patent foramen ovale closure using the Premere PFO occlusion system. Catheterization and Cardiovascular Interventions 68(5): 736-740, 2006

Percutaneous PFO closure using the Premere device occluder: initial experience. Revista Portuguesa de Cardiologia 28(11): 1225-1230, 2010

Transcatheter closure of patent foramen ovale in patients with paradoxical embolism using the Starflex occlusion device A single centre experience. European Journal of Neurology 8(Supplement 2): 12-13, March, 2001

Initial experience with the novel patent foramen ovale occlusion device Nit-Occlud® in patients with stroke or transient ischemic attack. Catheterization and Cardiovascular Interventions 85(7): 1262-1267, 2016

The BioSTAR(r) device versus the CardioSEAL(r) device in patent foramen ovale closure: comparison of mid-term efficacy and safety. Eurointervention 6(4): 498-504, 2011

Percutaneous patent foramen ovale closure: outcomes with the Premere and Amplatzer devices. Cardiovascular Revascularization Medicine 12(3): 164-169, 2011